Chemical Structure (Bortezomib 01)
Bortezomib Injection, Powder, Lyophilized, For Solution
Product Images NDC 67184-0530
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Bortezomib (NDC 67184-0530). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Bortezomib 02)
The text seems to be a graph with no clear title or context. The x-axis seems to represent the number of patients and the time in months. The y-axis seems to represent the percentage of patients. Without additional information it's impossible to provide a useful description.*
Figure 2 (Bortezomib 03)
This appears to be a table displaying the percentage of patients over a certain period of time. The top row seems to be the time in months, and the first column indicates the number of patients at risk. The second row has the abbreviation "MP" with different time intervals and corresponding numbers. There is also reference to a p-value from a log-rank test. However, without further context or information, it is difficult to determine the exact nature of the data represented.*
Figure 3 (Bortezomib 04)
Figure 4 (Bortezomib 05)
This appears to be a chart from a clinical study, likely involving the drugs Bortezomib and Dexamethasone. The chart displays the number of patients remaining after a certain timepoint, along with a p-value from a log-rank test. Without more context, it is unclear what the study was investigating or what the results mean.*
Figure 5 (Bortezomib 06)
This appears to be a table showing the number of patients who received R-CHOP or VcR-CAP treatment at different time points. The numbers "12", "148", "116" seem to represent the number of patients who received either treatment, and the time points are listed in months. However, without additional context it is not clear what R-CHOP or VcR-CAP are, or what the purpose of this table was.*
Figure 6 (Bortezomib 07)
Principal Display Panel (3.5 mg Vial Label)
Manufactured by Pramaceutea (Hainan) Co, Ltd, this is a single dose vial containing 3.5 mg/vial Bortezomib for Injection. The unused portion of the vial should be discarded due to it being a cytotoxic agent. The lot number is xoo0m00x.*
Principal Display Panel (3.5 mg Vial Carton)
Principal Display Panel Inside Flap (all Cartons) (Bortezomib 10)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
